Atrys Health (CHIX:ATRYE) Beginning Cash Position: €-0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ATRYE Atrys Health SA CHIX:ATRYE
65 GF Score
Price €6.08
GF Value €8.08
! 5 Warning Signs
View Full Analysis

What is Atrys Health Beginning Cash Position?

Atrys Health CHIX:ATRYE 65 Beginning Cash Position is €-0.0 Mil as of Dec. 2025. GuruFocus rates CHIX:ATRYE with a GF Score™ of 65/100 and a GF Value™ of €8.08. The stock has 5 warning signs investors should review.

Atrys Health's Beginning Cash Position for the quarter that ended in Dec. 2025 was €-0.0 Mil.

Atrys Health's quarterly Beginning Cash Position increased from Dec. 2024 (€0.0 Mil) to Jun. 2025 (€20.4 Mil) but then declined from Jun. 2025 (€20.4 Mil) to Dec. 2025 (€-0.0 Mil).

Atrys Health's annual Beginning Cash Position increased from Dec. 2023 (€34.3 Mil) to Dec. 2024 (€41.8 Mil) but then declined from Dec. 2024 (€41.8 Mil) to Dec. 2025 (€20.4 Mil).

Atrys Health Beginning Cash Position Related Terms

Atrys Health Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Atrys Health's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atrys Health Beginning Cash Position Chart

Atrys Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.48 35.13 34.30 41.83 20.37

Atrys Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 41.83 0.00 20.37 -0.00
CHIX:ATRYE
65GF Score
Atrys Health SA CHIX:ATRYE
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atrys Health Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €-0.0 Mil mean?
Atrys Health (CHIX:ATRYE) has a Beginning Cash Position of €-0.0 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Atrys Health and its competitors.
Is Atrys Health's Beginning Cash Position too high?
Atrys Health's current Beginning Cash Position is €-0.0 Mil. Overall, Atrys Health has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Atrys Health's Beginning Cash Position compare to VRTX and REGN?
Atrys Health's Beginning Cash Position of €-0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Atrys Health and its competitors. Atrys Health's current Beginning Cash Position is €-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atrys Health stock overvalued right now?
Atrys Health (CHIX:ATRYE) has a current Beginning Cash Position of €-0.0 Mil. The stock's GF Value™ is €8.08, compared to a current price of €6.08 — trading 24.8% below its estimated fair value. The current Beginning Cash Position is €-0.0 Mil. Atrys Health's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Atrys Health (CHIX:ATRYE), the current Beginning Cash Position is €-0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atrys Health (CHIX:ATRYE) Overvalued in 2026?

Based on GuruFocus' analysis, Atrys Health stock appears to be undervalued. The current stock price of €6.08 is trading 24.8% below its estimated GF Value™ of €8.08.

Key valuation signals for CHIX:ATRYE:

  • Beginning Cash Position: €-0.0 Mil
  • GF Value™: €8.08 vs. price of €6.08 (24.8% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ATRYE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atrys Health Business Description

Other Exchanges ATRY:SpainA2T:Germany
Address Calle Provenca, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
65GF Score

Get the complete analysis for CHIX:ATRYE

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.08
Price
€8.08
GF Value